Deutsche Bank Ag\ Gilead Sciences, Inc. Put Options Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $60,216 - $67,458	-963 Reduced 55.7%	766 $49,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $12,955 - $16,906	-214 Reduced 11.01%	1,729 $108,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $53,460 - $59,190	-750 Reduced 27.85%	1,943 $150,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $97,060 - $113,217	1,496 Added 124.98%	2,693 $190,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $402,222 - $490,353	-5,522 Reduced 82.18%	1,197 $90,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $104,234 - $122,356	1,465 Added 27.88%	6,719 $481,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $378,865 - $449,059	5,254	5,254 $425,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.